GlassScriptPhysician profile
Anthony Mangia
NPI 1750320040
$8,348.47
in general payments reported to CMS, 2019-2025
26 companies · $883 in 2025
The $883 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,439 · 2020: $1,073 · 2021: $1,635 · 2022: $926 · 2023: $1,265 · 2024: $1,128 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,265 · Education: $10.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,265.00 |
| Education | $10.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $3,443.00 | 2019-2025 | Biktarvy |
| Viiv Healthcare Company | $1,513.14 | 2019-2025 | Dovato, Cabenuva, Apretude |
| Merck Sharp & Dohme LLC | $1,038.23 | 2019-2025 | Dificid, Zerbaxa, Pifeltro |
| Abbvie INC. | $477.76 | 2019-2025 | |
| Janssen Biotech, INC. | $463.10 | 2019-2023 | Symtuza |
| Emd Serono, INC. | $219.40 | 2019-2025 | Serostim |
| Janssen Products, LP | $171.00 | 2019-2021 | |
| Insmed, INC. | $140.62 | 2019-2025 | Arikayce |
| Glaxosmithkline, LLC. | $127.62 | 2021-2024 | Trelegy Ellipta |
| Theratechnologies INC. | $124.00 | 2019-2022 | |
| Allergan, INC. | $104.63 | 2019-2020 | |
| Melinta Therapeutics, LLC | $80.80 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $79.70 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $63.98 | 2019 | |
| Napo Pharmaceuticals INC | $59.43 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $39.73 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Aytu Biopharma, INC. | $39.02 | 2020 | |
| Endo Pharmaceuticals INC. | $29.67 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.94 | 2021 | |
| Shionogi INC | $27.10 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.46 | 2023 | |
| Intra-Sana Laboratories | $15.57 | 2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Ucb, INC. | $12.56 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.56 | 2021 | |
| Lilly USA, LLC | $11.41 | 2019 | |
| Acerus Pharmaceuticals Corporation | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mangia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.